Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Tracking every penny for budgeting provides clarity and control over finances. This intro highlights the benefits and sets you up for smarter spending.
26,876 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A former SWIFT official punctured rumors that Ripple XRP could be integrated into SWIFT's payments network. At the sa...
Cisco stock is at a pivotal crossroads as AI infrastructure demand accelerates. This article weighs targets, catalyst...
A value-driven, catalyst-led small-cap approach is drawing attention as investors seek mispriced names with clear ups...
Defensive staples shares are delivering steady gains even as the broader market wobbles. Retirees are taking note as ...
A divided fed signals rate-cut bets as doves likely push for easing this year. Markets are recalibrating as investors...
Two next-gen income ETFs are quietly beating JEPI in 2026, driven by selective options writing and global dividend ex...
Coinbase CEO Brian Armstrong refutes accusations of lobbying against a Bitcoin de minimis tax exemption as lawmakers ...
President Trump has granted a 60-day waiver of the Jones Act to accelerate energy shipments within U.S. waters, in a ...
A sweeping regulatory update defines most cryptocurrencies as commodities or digital tools, sparking a rally in crypt...
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
UBS downgraded Dell Technologies to Neutral after a blistering 157% rally, raising the target to $243 and signaling v...